Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Trial of CM-AT in Children With Autism

ClinicalTrials.gov ID: NCT00881452

Public ClinicalTrials.gov record NCT00881452. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 1:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether CM-AT is safe and effective in treating the core symptoms of autism.

Study identification

NCT ID
NCT00881452
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Curemark
Industry
Enrollment
182 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
3 Years to 8 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2009 (Type not available)
Primary completion
Jun 2011 (Actual)
Completion
Sep 2011 (Actual)
Last update posted
Apr 19, 2018

2009 – 2011

United States locations

U.S. sites
19
U.S. states
15
U.S. cities
19
Facility City State ZIP Site status
Southwest Autism Research and Resource Center Phoenix Arizona 85006 —
University of California, Davis, M.I.N.D. Institute Sacramento California 95817 —
University of California, San Francisco San Francisco California 94143 —
Neuropsychiatric Research Center of Orange County Santa Ana California 92701 —
Lake Mary Pediatrics Orange City Florida 32763 —
Institute for Behavioral Medicine Smyrna Georgia 30080 —
Alexian Brothers Center for Psychiatric Research Hoffman Estates Illinois 60169 —
Louisiana State University Health Science Center Shreveport Louisiana 71103 —
Saint Peters University Hospital New Brunswick New Jersey 08901 —
Mount Sinai School of Medicine New York New York 10029 —
University of North Carolina Chapel Hill North Carolina 27514 —
Ohio State University Columbus Ohio 43210 —
Oklahoma University Child Study Center Oklahoma City Oklahoma 73117 —
Cyn3rgy Research Gresham Oregon 97030 —
Hershey Medical Center Hershey Pennsylvania 17033 —
Drexel University Philadelphia Pennsylvania 19124 —
University of Pittsburgh Pittsburgh Pennsylvania 15260 —
University of Texas, Houston Houston Texas 77054 —
Westside Medical Clinton Utah 84015 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00881452, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 19, 2018 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00881452 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →